| 6579871 |
Methods of using novel compounds as neuro-protective agents |
John Kevin Shadle, Lawrence Joseph Heinz, Michael LeRoy Phillips, John Robert Rizzo, Benjamin Alan Anderson +2 more |
2003-06-17 |
$179,653,000 |
| 6472387 |
Methods of using compounds as neuro-protective agents |
John Kevin Shadle, Lawrence Joseph Heinz, Michael LeRoy Phillips, John Robert Rizzo, Benjamin Alan Anderson +2 more |
2002-10-29 |
$136,068,000 |
| 6448396 |
Compounds useful as neuro-protective agents |
Benjamin Alan Anderson, Lawrence Joseph Heinz, Michael LeRoy Phillips, John Allan Rieck, III, John Robert Rizzo +2 more |
2002-09-10 |
$109,326,000 |
| 6423709 |
Methods of using novel compounds as neuro-protective agents |
John Kevin Shadle, Lawrence Joseph Heinz, Michael LeRoy Phillips, John Robert Rizzo, Benjamin Alan Anderson +2 more |
2002-07-23 |
$360,199,000 |
| 6380213 |
Compounds useful as neuro-protective agents |
John Kevin Shadle, Lawrence Joseph Heinz, Michael LeRoy Phillips, John Robert Rizzo, Benjamin Alan Anderson +2 more |
2002-04-30 |
$98,315,000 |
| 6251928 |
Treatment of alzheimer's disease employing inhibitors of cathepsin D |
Michael LeRoy Phillips, Jon K. Reel, John Kevin Shadle, Sandra K. Sigmund, Richard L. Simon +1 more |
2001-06-26 |
$203,013,000 |
| 6166216 |
Compounds useful as neuro-protective agents |
John Kevin Shadle, Lawrence Joseph Heinz, Michael LeRoy Phillips, John Robert Rizzo, Benjamin Alan Anderson +2 more |
2000-12-26 |
$442,494,000 |
| 6156748 |
Compounds useful as neuro-protective agents |
John Kevin Shadle, Lawrence Joseph Heinz, Michael LeRoy Phillips, John Robert Rizzo, Benjamin Alan Anderson +2 more |
2000-12-05 |
$334,564,000 |
| 5981523 |
Compounds and methods for treating multiple sclerosis |
Michael LeRoy Phillips |
1999-11-09 |
$103,079,000 |
| 5952360 |
Method for treating neuropathic pain |
Harlan E. Shannon |
1999-09-14 |
$85,004,000 |
| 5942530 |
Method for treating pain |
Harlan E. Shannon |
1999-08-24 |
$231,679,000 |
| 5814646 |
Inhibitors of amyloid beta-protein production |
Lawrence Joseph Heinz, Michael LeRoy Phillips, Jon K. Reel, John Kevin Shadle, Richard L. Simon +1 more |
1998-09-29 |
$221,221,000 |
| 5747517 |
Benzylidene rhodanines |
Michael LeRoy Phillips, Jon K. Reel, John Kevin Shadle, Sandra K. Sigmund, Richard L. Simon +1 more |
1998-05-05 |
$134,602,000 |
| 5731336 |
Method for treating multiple sclerosis |
Ann E. Kingston |
1998-03-24 |
$70,695,000 |
| 5716975 |
Compounds useful as hypoglycemic agents and for treating Alzheimer's disease |
Juliana Maude Bue-Valleskey, David C. Hunden, Charles D. Jones, Walter N. Shaw |
1998-02-10 |
$225,440,000 |
| 5691367 |
Aryl-substituted rhodanine derivatives |
— |
1997-11-25 |
$74,311,000 |
| 5674887 |
Prevention of bone resorption |
David R. Blake, Mone Zaidi |
1997-10-07 |
$90,547,000 |
| 5661168 |
Hypoglycemic agents |
Juliana Maude Bue-Valleskey, David C. Hunden, Charles D. Jones, Walter N. Shaw |
1997-08-26 |
$86,535,000 |
| 5633283 |
Method for treating multiple sclerosis |
Ann E. Kingston |
1997-05-27 |
$75,462,000 |
| 5552439 |
Method of treating inflammatory bowel disease |
— |
1996-09-03 |
$12,735,000 |
| 5523314 |
Compounds useful as hypoglycemic agents and for treating Alzheimer's disease |
Juliana Maude Bue-Valleskey, David C. Hunden, Charles D. Jones, Walter N. Shaw |
1996-06-04 |
$77,588,000 |
| 5476865 |
Methods of inhibiting bone loss |
Masahiko Sato |
1995-12-19 |
$49,872,000 |
| 5441984 |
Urea, thiourea and guanidine derivatives |
William F. Heath, Jr., John Kevin Shadle |
1995-08-15 |
$12,577,000 |
| 5436258 |
Prevention of bone resorption |
David R. Blake, Mone Zaidi |
1995-07-25 |
$56,310,000 |
| 5393786 |
Method for treating inflammation, ischemia-induced cell damage and muscular dystrophy |
James A. Clemens |
1995-02-28 |
$24,532,000 |
